BOTHELL, Wash., March 15 /PRNewswire-FirstCall/ -- Cardiac Science Corporation , a global leader in advanced cardiac monitoring and defibrillation products, announced today that Chief Financial Officer Michael Matysik will speak at the fifth annual Invest Northwest 2006 CEO and Investor Forum on Tuesday, March 21, 2006 at 9:00 a.m. (Pacific Time). The conference is being held at the Bell Harbor International Conference Center in Seattle from March 21-22, 2006.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO )
Mr. Matysik will be discussing recent business accomplishments and related financial information regarding Cardiac Science Corporation. The presentation will also be broadcast live via an on-line audio cast available at www.cardiacscience.com.
Invest Northwest is the leading investment conference for the Pacific Northwest life sciences community. The two-day conference is hosted by the Washington Biotechnology and Biomedical Association, in collaboration with British Columbia Biotech, British Columbia MedTech, BioAlberta, Idaho Bioscience Association, Montana Bioscience Alliance and the Oregon Bioscience Association.
About Cardiac Science Corporation
Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators, electrocardiographs, stress test systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, patient monitor- defibrillators and cardiology data management systems. Cardiac Science Corporation also sells a variety of related products and consumables, and provides a comprehensive portfolio of training, maintenance and support services.
The company is the successor to various entities that have owned and operated cardiology-related businesses, which sold products under the trusted brand names Burdick(R), Powerheart(R), and Quinton(R). Cardiac Science is headquartered in Bothell, WA, and also has operations in Lake Forest, California, Deerfield, Wisconsin, Shanghai, China, Copenhagen, Denmark and Manchester, United Kingdom.
Forward Looking Statements
This press release contains forward-looking statements. The words “believe,” “expect,” “intend,” anticipate,” variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. Forward-looking statements in this press release include those that infer or imply that we will be able to successfully commercialize applications incorporating new diagnostic cardiology techniques. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause or contribute to such varying results and other risks are more fully described in the registration statement on Form S-4/A that was filed by Cardiac Science Corporation under the name CSQ Holding Company on July 28, 2005, under the caption “Risk Factors,” and in the Annual Reports of Quinton Cardiology Systems, Inc. and Cardiac Science, Inc. on Form 10-K for the year ended December 31, 2004, under the captions “Certain Factors that May Affect Future Results,” in Cardiac Science Corporation’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2005 under the caption “Certain Factors that May Affect Future Results” and in other documents, we file with the Securities and Exchange Commission. Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.
Media Contacts Mike Matysik Cardiac Science Corp. Sr. Vice President and CFO 425-402-2009 Aaron Blank The Fearey Group for Cardiac Science Corp. 206-343-1543
Photo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk photodesk@prnewswire.comCardiac Science Corporation
CONTACT: media, Mike Matysik, Sr. Vice President and CFO of CardiacScience Corp., +1-425-402-2009; or Aaron Blank of The Fearey Group,+1-206-343-1543, for Cardiac Science Corp.
Web site: http://www.cardiacscience.com/
